Mechanisms of triglyceride metabolism in patients with bile acid diarrhea
Open Access
- 1 January 2016
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 22 (30) , 6757-63
Abstract
Bile acids (BAs) are essential for the absorption of lipids. BA synthesis is inhibited through intestinal farnesoid X receptor (FXR) activity. BA sequestration is known to influence BA metabolism and control serum lipid concentrations. Animal data has demonstrated a regulatory role for the FXR in triglyceride metabolism. FXR inhibits hepatic lipogenesis by inhibiting the expression of sterol regulatory element binding protein 1c via small heterodimer primer activity. Conversely, FXR promotes free fatty acids oxidation by inducing the expression of peroxisome proliferator-activated receptor α. FXR can reduce the expression of microsomal triglyceride transfer protein, which regulates the assembly of very low-density lipoproteins (VLDL). FXR activation in turn promotes the clearance of circulating triglycerides by inducing apolipoprotein C-II, very low-density lipoproteins receptor (VLDL-R) and the expression of Syndecan-1 together with the repression of apolipoprotein C-III, which increases lipoprotein lipase activity. There is currently minimal clinical data on triglyceride metabolism in patients with bile acid diarrhoea (BAD). Emerging data suggests that a third of patients with BAD have hypertriglyceridemia. Further research is required to establish the risk of hypertriglyceridaemia in patients with BAD and elicit the mechanisms behind this, allowing for targeted treatment.Keywords
This publication has 33 references indexed in Scilit:
- Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor β-KlothoProceedings of the National Academy of Sciences, 2012
- Inhibition of Intestinal Bile Acid Transporter Slc10a2 Improves Triglyceride Metabolism and Normalizes Elevated Plasma Glucose Levels in MicePLOS ONE, 2012
- Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXRNature Reviews Molecular Cell Biology, 2012
- Bile Acids and Metabolic RegulationDiabetes Care, 2009
- Clinical Utility of Bile Acid Sequestrants in the Treatment of Dyslipidemia: A Scientific ReviewSouthern Medical Journal, 2006
- Bile Acid Reduces the Secretion of Very Low Density Lipoprotein by Repressing Microsomal Triglyceride Transfer Protein Gene Expression Mediated by Hepatocyte Nuclear Factor-4Journal of Biological Chemistry, 2004
- The farnesoid X receptor induces very low density lipoprotein receptor gene expressionFEBS Letters, 2004
- Syndecan-1 Expression Is Regulated in an Isoform-specific Manner by the Farnesoid-X ReceptorJournal of Biological Chemistry, 2003
- Regulation of hepatic cholesterol metabolism in the rat in vivo: Effect of a synthetic fat-free diet on sterol synthesis and low-density lipoprotein transportBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein CatabolismNew England Journal of Medicine, 1980